Menu

The FDA Just Flagged a Rare Vision Risk for GLP-1 Users. Here’s Why It Should Be on Your Radar.
📰

The FDA Just Flagged a Rare Vision Risk for GLP-1 Users. Here’s Why It Should Be on Your Radar.

#menshealth#health#naion#risk#warning
Reading 0:00
15s threshold

3 min read

The FDA is warning about a risk of sudden blindness for people on GLP-1s.

Previous studies have also pointed out a link between the meds and this complication.

Doctors stress that the risk is still “extremely rare.”

For years, there have been rumblings and even research about a rare but serious condition that’s been linked to taking a GLP-1 medication. Now, the Food and Drug Administration is doing something about it.

The FDA just released a drug safety communication to warn patients and healthcare providers about the potential increased risk of developing non-arteritic anterior ischemic optic neuropathy (NAION) when you take a GLP-1 medication. NAION is a rare condition that can lead to vision loss in one eye, and it can be permanent.

Again, this isn't the first time concerns have been raised about the risk of NAION.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.